Zions Bancorporation N.A. boosted its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 40.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,006 shares of the company's stock after purchasing an additional 2,035 shares during the quarter. Zions Bancorporation N.A.'s holdings in Procter & Gamble were worth $1,175,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. NewSquare Capital LLC grew its stake in shares of Procter & Gamble by 933.3% in the 4th quarter. NewSquare Capital LLC now owns 155 shares of the company's stock worth $26,000 after buying an additional 140 shares during the last quarter. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble in the third quarter worth $33,000. LFA Lugano Financial Advisors SA bought a new position in shares of Procter & Gamble during the fourth quarter valued at $34,000. Atlantic Private Wealth LLC raised its position in shares of Procter & Gamble by 95.3% in the 4th quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock worth $35,000 after purchasing an additional 101 shares during the last quarter. Finally, Noble Wealth Management PBC purchased a new stake in Procter & Gamble during the 4th quarter valued at about $39,000. Institutional investors own 65.77% of the company's stock.
Analysts Set New Price Targets
Several research analysts have issued reports on the stock. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. JPMorgan Chase & Co. decreased their price objective on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating for the company in a report on Thursday, January 16th. Barclays reiterated an "equal weight" rating on shares of Procter & Gamble in a research note on Thursday. UBS Group restated a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. Finally, Piper Sandler dropped their price objective on Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating on the stock in a research report on Monday, February 24th. Seven investment analysts have rated the stock with a hold rating, twelve have given a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $181.82.
Read Our Latest Analysis on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 18,000 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, February 25th. The shares were sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the transaction, the chief executive officer now owns 22,051 shares of the company's stock, valued at $3,785,274.66. The trade was a 44.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Marc S. Pritchard sold 90,450 shares of the firm's stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the sale, the insider now owns 172,814 shares in the company, valued at $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 143,450 shares of company stock worth $23,988,008. 0.18% of the stock is owned by company insiders.
Procter & Gamble Stock Performance
NYSE PG traded down $0.74 during trading hours on Friday, hitting $167.97. 2,735,239 shares of the company's stock traded hands, compared to its average volume of 6,879,883. The Procter & Gamble Company has a 52 week low of $153.52 and a 52 week high of $180.43. The firm has a market capitalization of $393.87 billion, a P/E ratio of 26.75, a P/E/G ratio of 3.76 and a beta of 0.41. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The business's fifty day moving average price is $168.47 and its two-hundred day moving average price is $169.46.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. During the same quarter in the previous year, the firm posted $1.84 EPS. The company's revenue for the quarter was up 2.1% compared to the same quarter last year. Equities research analysts predict that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.40%. The ex-dividend date of this dividend was Friday, January 24th. Procter & Gamble's dividend payout ratio (DPR) is currently 64.01%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.